RNA m6A methylation modulates airway inflammation in allergic asthma via PTX3-dependent macrophage homeostasis

Xiao Han1,2, Lijuan Liu3, Saihua Huang4,5

  • 1Institute of Pediatrics, Children's Hospital of Fudan University, National Children's Medical Center, and the Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China. sqhx12@126.com.

Nature Communications
|November 13, 2023
PubMed

Insights

The study reveals that low levels of METTL3, an enzyme crucial for N6-methyladenosine (m6A) modification, worsen allergic asthma by promoting M2 macrophage activation. This finding offers new therapeutic targets for allergic airway inflammation.

Area of Science:

  • Immunology
  • Epigenetics
  • Molecular Biology

Background:

  • N6-methyladenosine (m6A) is a prevalent mRNA modification impacting biological processes.
  • The role of m6A in allergic asthma and macrophage homeostasis is not well understood.

Purpose of the Study:

  • To investigate the function of m6A methyltransferases METTL3 in allergic asthma.
  • To elucidate the mechanisms by which METTL3 regulates macrophage homeostasis and allergic airway inflammation.

Main Methods:

  • Analysis of METTL3 expression in macrophages from asthma patients.
  • Conditional knockout of Mettl3 in myeloid cells.
  • Loss and gain functional studies involving PI3K/AKT and JAK/STAT6 signaling pathways.
  • m6A-sequencing to identify target mRNAs and regulatory interactions.

Main Results:

  • Reduced METTL3 expression in macrophages from childhood allergic asthma patients.
  • Mettl3 deficiency in myeloid cells exacerbates allergic airway inflammation by enhancing Th2 response and M2 macrophage activation.
  • METTL3 suppresses M2 macrophage activation via PI3K/AKT and JAK/STAT6 signaling.
  • Loss of METTL3 leads to impaired m6A-YTHDF3-dependent degradation of PTX3 mRNA, correlating with asthma severity.
  • METTL3/YTHDF3-m6A/PTX3 interactions regulate macrophage autophagy by modulating STX17 expression.

Conclusions:

  • METTL3 plays a critical role in suppressing M2 macrophage activation and mitigating allergic airway inflammation.
  • The METTL3/YTHDF3-m6A/PTX3 axis is a key regulator of macrophage homeostasis and allergic asthma.
  • Targeting the m6A pathway, particularly METTL3, presents a potential therapeutic strategy for allergic asthma.